Sickle Cell Anemia Testing And Screening Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : July 2020 Pages : 160 Category: Pharma & Healthcare Report Code : HC0812272
Sickle Cell Anemia Testing And Screening Market by Type (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests, Other Tests) Application (Government Labs, Private Labs, Corporate Labs, PPP (Public-Private-Partnerships) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Sickle Cell Anemia Testing And Screening Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Sickle Cell Anemia Testing And Screening determines the sickle cell disease (SCD) or sickle cell trait. People with SCD have red blood cells (RBCs) that are abnormally shaped.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- STRECK, INC.
- Daktari Diagnostics
- BIOMEDOMICS INC.
- Laboratory Corporation of America Holdings
- Request A Test, Ltd.
- HALCYON BIOMEDICAL INCORPORATED
- Silver Lake Research Corporation
- HEMOTYPE
- HEMEX HEALTH
- Bio-Rad Laboratories, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Sickle Cell Anemia Testing And Screening Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Hemoglobin Electrophoresis
o High-performance Liquid Chromatography (HPLC)
o Point-of-Care Tests
o Other Tests
· Sickle Cell Anemia Testing And Screening Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Government Labs
o Private Labs
o Corporate Labs
o PPP (Public-Private-Partnerships)
· Sickle Cell Anemia Testing And Screening Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o STRECK, INC.
o Daktari Diagnostics
o BIOMEDOMICS INC.
o Laboratory Corporation of America Holdings
o Request A Test, Ltd.
o HALCYON BIOMEDICAL INCORPORATED
o Silver Lake Research Corporation
o HEMOTYPE
o HEMEX HEALTH
o Bio-Rad Laboratories, Inc.
· Sickle Cell Anemia Testing And Screening Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Sickle Cell Anemia Testing And Screening Market , By Country
o U.S. Sickle Cell Anemia Testing And Screening Market
o Canada Sickle Cell Anemia Testing And Screening Market
o Mexico Sickle Cell Anemia Testing And Screening Market
o Europe
§ Europe Sickle Cell Anemia Testing And Screening Market , By Country
o Germany Sickle Cell Anemia Testing And Screening Market
o UK Sickle Cell Anemia Testing And Screening Market
o France Sickle Cell Anemia Testing And Screening Market
o Russia Sickle Cell Anemia Testing And Screening Market
o Italy Sickle Cell Anemia Testing And Screening Market
o Rest of Europe Sickle Cell Anemia Testing And Screening Market
o Asia-Pacific
§ Asia-Pacific Sickle Cell Anemia Testing And Screening Market , By Country
o China Sickle Cell Anemia Testing And Screening Market
o Japan Sickle Cell Anemia Testing And Screening Market
o South Korea Sickle Cell Anemia Testing And Screening Market
o India Sickle Cell Anemia Testing And Screening Market
o Southeast Asia Sickle Cell Anemia Testing And Screening Market
o Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market
o South America
§ South America Sickle Cell Anemia Testing And Screening Market , By Country
o Brazil Sickle Cell Anemia Testing And Screening Market
o Argentina Sickle Cell Anemia Testing And Screening Market
o Columbia Sickle Cell Anemia Testing And Screening Market
o Rest of South America Sickle Cell Anemia Testing And Screening Market
o Middle East and Africa
§ Middle East and Africa Sickle Cell Anemia Testing And Screening Market , By Country
o Saudi Arabia Sickle Cell Anemia Testing And Screening Market
o UAE Sickle Cell Anemia Testing And Screening Market
o Egypt Sickle Cell Anemia Testing And Screening Market
o Nigeria Sickle Cell Anemia Testing And Screening Market
o South Africa Sickle Cell Anemia Testing And Screening Market
o Rest of MEA Sickle Cell Anemia Testing And Screening Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Sickle Cell Anemia Testing And Screening Market, By Type
5.1. Introduction
5.2. Global Sickle Cell Anemia Testing And Screening Revenue and Market Share by Type (2017-2021)
5.2.1. Global Sickle Cell Anemia Testing And Screening Revenue and Revenue Share by Type (2017-2021)
5.3. Hemoglobin Electrophoresis
5.3.1. Global Hemoglobin Electrophoresis Revenue and Growth Rate (2017-2021)
5.4. High-performance Liquid Chromatography (HPLC)
5.4.1. Global High-performance Liquid Chromatography (HPLC) Revenue and Growth Rate (2017-2021)
5.5. Point-of-Care Tests
5.5.1. Global Point-of-Care Tests Revenue and Growth Rate (2017-2021)
5.6. Other Tests
5.6.1. Global Other Tests Revenue and Growth Rate (2017-2021)
6. Sickle Cell Anemia Testing And Screening Market, By Applications
6.1. Introduction
6.2. Global Sickle Cell Anemia Testing And Screening Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Sickle Cell Anemia Testing And Screening Revenue and Revenue Share by Applications (2017-2021)
6.3. Government Labs
6.3.1. Global Government Labs Revenue and Growth Rate (2017-2021)
6.4. Private Labs
6.4.1. Global Private Labs Revenue and Growth Rate (2017-2021)
6.5. Corporate Labs
6.5.1. Global Corporate Labs Revenue and Growth Rate (2017-2021)
6.6. PPP (Public-Private-Partnerships)
6.6.1. Global PPP (Public-Private-Partnerships) Revenue and Growth Rate (2017-2021)
7. Sickle Cell Anemia Testing And Screening Market, By Region
7.1. Introduction
7.2. Global Sickle Cell Anemia Testing And Screening Revenue and Market Share by Regions
7.2.1. Global Sickle Cell Anemia Testing And Screening Revenue by Regions (2017-2021)
7.3. North America Sickle Cell Anemia Testing And Screening by Countries
7.3.1. North America Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2021)
7.3.2. North America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Sickle Cell Anemia Testing And Screening by Countries
7.4.1. Europe Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2021)
7.4.2. Europe Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Sickle Cell Anemia Testing And Screening by Countries
7.5.1. Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Sickle Cell Anemia Testing And Screening by Countries
7.6.1. South America Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2021)
7.6.2. South America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Sickle Cell Anemia Testing And Screening by Countries
7.7.1. Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. STRECK, INC.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Daktari Diagnostics
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. BIOMEDOMICS INC.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Laboratory Corporation of America Holdings
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Request A Test, Ltd.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. HALCYON BIOMEDICAL INCORPORATED
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Silver Lake Research Corporation
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. HEMOTYPE
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. HEMEX HEALTH
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Bio-Rad Laboratories, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.1. Global Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Sickle Cell Anemia Testing And Screening Market Forecast by Regions (2022-2027)
9.2.1. North America Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.1.1. United States Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.1.2. Canada Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.1.3. Mexico Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2. Europe Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.1. Germany Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.2. France Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.3. UK Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.4. Russia Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.5. Italy Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3. Asia-Pacific Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.1. China Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.2. Japan Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.3. Korea Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.4. India Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.4. South America Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.4.1. Brazil Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.4.2. Argentina Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.4.3. Columbia Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.4.4. Rest of South America Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5. Middle East and Africa Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.3. Egypt Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.4. Nigeria Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.5. South Africa Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.6. Turkey Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Market Forecast (2022-2027)
9.3. Sickle Cell Anemia Testing And Screening Market Forecast by Type (2022-2027)
9.3.1. Sickle Cell Anemia Testing And Screening Forecast by Type (2022-2027)
9.3.2. Sickle Cell Anemia Testing And Screening Market Share Forecast by Type (2022-2027)
9.4. Sickle Cell Anemia Testing And Screening Market Forecast by Applications (2022-2027)
9.4.1. Sickle Cell Anemia Testing And Screening Forecast by Applications (2022-2027)
9.4.2. Sickle Cell Anemia Testing And Screening Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Sickle Cell Anemia Testing And Screening Revenue and Revenue Share by Type (2017-2019)
Figure Global Hemoglobin Electrophoresis Revenue and Growth Rate (2017-2019)
Figure Global High-performance Liquid Chromatography (HPLC) Revenue and Growth Rate (2017-2019)
Figure Global Point-of-Care Tests Revenue and Growth Rate (2017-2019)
Figure Global Other Tests Revenue and Growth Rate (2017-2019)
Table Global Sickle Cell Anemia Testing And Screening Revenue and Revenue Share by Applications (2017-2019)
Figure Global Government Labs Revenue and Growth Rate (2017-2019)
Figure Global Private Labs Revenue and Growth Rate (2017-2019)
Figure Global Corporate Labs Revenue and Growth Rate (2017-2019)
Figure Global PPP (Public-Private-Partnerships) Revenue and Growth Rate (2017-2019)
Table Global Sickle Cell Anemia Testing And Screening Revenue by Regions (2017-2019)
Figure North America Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure North America Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2019)
Figure North America Sickle Cell Anemia Testing And Screening by Countries (2017-2019)
Figure North America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2019)
Figure United States Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure United States Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Canada Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Mexico Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Europe Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2019)
Figure Europe Sickle Cell Anemia Testing And Screening by Countries (2017-2019)
Figure Europe Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2019)
Figure Germany Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Germany Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure France Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure UK Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Russia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Italy Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening by Countries (2017-2019)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2019)
Figure China Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure China Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Japan Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Korea Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure India Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure South America Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2019)
Figure South America Sickle Cell Anemia Testing And Screening by Countries (2017-2019)
Figure South America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Brazil Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Argentina Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Columbia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening by Countries (2017-2019)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Egypt Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Nigeria Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure South Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Turkey Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Table STRECK, INC. Sickle Cell Anemia Testing And Screening Financial Overview
Table Daktari Diagnostics Sickle Cell Anemia Testing And Screening Financial Overview
Table BIOMEDOMICS INC. Sickle Cell Anemia Testing And Screening Financial Overview
Table Laboratory Corporation of America Holdings Sickle Cell Anemia Testing And Screening Financial Overview
Table Request A Test, Ltd. Sickle Cell Anemia Testing And Screening Financial Overview
Table HALCYON BIOMEDICAL INCORPORATED Sickle Cell Anemia Testing And Screening Financial Overview
Table Silver Lake Research Corporation Sickle Cell Anemia Testing And Screening Financial Overview
Table HEMOTYPE Sickle Cell Anemia Testing And Screening Financial Overview
Table HEMEX HEALTH Sickle Cell Anemia Testing And Screening Financial Overview
Table Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing And Screening Financial Overview
Figure Global Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2019-2027)
Table Sickle Cell Anemia Testing And Screening Market Forecast by Regions (2019-2027)
Figure North America Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure United States Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Canada Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Mexico Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Europe Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Germany Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure France Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure UK Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Russia Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Italy Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure China Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Japan Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Korea Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure India Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure South America Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Brazil Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Argentina Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Columbia Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Egypt Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Nigeria Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure South Africa Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Turkey Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Market Forecast (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Forecast by Type (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Market Share Forecast by Type (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Forecast by Type (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Forecast by Applications (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Market Share Forecast by Applications (2019-2027)
Figure Global Sickle Cell Anemia Testing And Screening Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|